- Home
- SUPN vs INTR Comparison
SUPN vs INTR Comparison
Compare SUPN & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- INTR
- Stock Information
- Founded
- SUPN 2005
- INTR 1994
- Country
- SUPN United States
- INTR Brazil
- Employees
- SUPN N/A
- INTR N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- INTR
- Sector
- SUPN Health Care
- INTR
- Exchange
- SUPN Nasdaq
- INTR Nasdaq
- Market Cap
- SUPN 1.7B
- INTR 2.1B
- IPO Year
- SUPN 2012
- INTR N/A
- Fundamental
- Price
- SUPN $32.90
- INTR $5.68
- Analyst Decision
- SUPN Hold
- INTR Buy
- Analyst Count
- SUPN 2
- INTR 4
- Target Price
- SUPN $36.00
- INTR $6.48
- AVG Volume (30 Days)
- SUPN 787.3K
- INTR 3.8M
- Earning Date
- SUPN 05-07-2025
- INTR 05-07-2025
- Dividend Yield
- SUPN N/A
- INTR 1.43%
- EPS Growth
- SUPN 6500.00
- INTR 176.00
- EPS
- SUPN 1.32
- INTR 0.33
- Revenue
- SUPN $661,817,000.00
- INTR $743,862,312.00
- Revenue This Year
- SUPN N/A
- INTR $81.95
- Revenue Next Year
- SUPN $8.67
- INTR $17.31
- P/E Ratio
- SUPN $24.90
- INTR $16.76
- Revenue Growth
- SUPN 8.94
- INTR 43.28
- 52 Week Low
- SUPN $25.53
- INTR $3.88
- 52 Week High
- SUPN $40.28
- INTR $7.84
- Technical
- Relative Strength Index (RSI)
- SUPN 46.17
- INTR 53.88
- Support Level
- SUPN $31.69
- INTR $5.52
- Resistance Level
- SUPN $32.90
- INTR $6.08
- Average True Range (ATR)
- SUPN 0.96
- INTR 0.21
- MACD
- SUPN 0.29
- INTR -0.00
- Stochastic Oscillator
- SUPN 89.25
- INTR 56.70
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.